Τόμος 27 (2009) – Τεύχος 2 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 27 (2009) – Issue 2 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Χαρά Σταύρακα, Τριανταφυλλιά Μπουτσιάδου, Μαρία Μυρωνίδου-Τζουβελέκη

Α’ Εργαστήριο Φαρμακολογίας, Ιατρική Σχολή, Αριστοτέλειο Πανεπιστήμιο, Θεσσαλονίκη, Ελλάς

Chara Stavraka, Triantafyllia Boutsiadou, Maria Mironidou-Tzouveleki

A’ Laboratory of Pharmacology, Medical School, Aristotle University of Thessaloniki, Greece

2. Dalsgaard-Nielsen T.: Some aspects of the epidemiology of migraine in Denmark. Headache 10: 14-23 (1970)

3. Lipton R.B., Silberstein S.D., Stewart W.F.: An update on the epidemiology of migraine. Headache 34: 319–328 (1994)

4. Mortimer M.J., Kay J., Jaron A.: Epidemiology of headache and childhood migraine in an urban general practice using ad hoc, Vahlquist and IHS criteria. Dev. Med. Child Neurol. 34: 1095-1101 (1992)

5. Valquist B.: Migraine in children. Int. Arch. Allergy 7: 348-355 (1995)

6. Small P., Waters W.E.: Headache and migraine in a comprehensive school. In: (W.E. Waters, ed.) The Epidemiology of Migraine. Pp. 56-67, Boehringer Ingelheim, Ltd, Bracknell-Berkshire, England, 1974

7. Sillanpaa M.: Prevalence of migraine and other headache in Finnish children starting school. Headache 15: 288-290 (1976)

8. Stewart W.F, Liner M.S, Celentano D.D., Van Natta M., Siegler D.: Age and sex-specific incidence rates of migraine with and without visual aura. Am. J. Epidemiol. 34: 1111-1120 (1991)

9. Stewart W.F., Lipton R.B., Celentano D.D., Reed M.L.: Prevalence of migraine headache in the United States. JAMA 267: 64-69 (1992)

10. Lewis D.: Headaches in children and adolescents. Curr. Probl. Peditr. Adoles. Health Care 37: 207-246 (2007)

11. Lipton R.B., Stewart W.F., Diamond S., Diamond M.L., Reed M.: Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41: 646-657 (2001)

12. Pietrobon D., Striessnig J.: Neurobiology of migraine. Nat. Rev. 4: 386-398 (2003)

13. Ward T.N., Levin M.: Diagnosis and pathophysiology of migraine. Exp. Rev. Neurother. 4: 383-390 (2004)

14. Silberstein S.: Migraine. Lancet 31: 381-391 (2004)

15. Burstein R., Yarnitsky D., Goor-Aryeh I., et al.: An association between migraine and cutaneous allodynia. Ann. Neurol. 47: 614-624 (2000)

16. Burstein R., Collins B., Jakubowski M.: Defeating migraine pain with Triptans: a race against the development of cutaneous allodynia. Ann. Neurol. 55: 19-26 (2004)

17. Burstein R., Jakubowski M.: Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann. Neurol. 55: 27-36 (2004)

18. Wöber C., Brannath W., Schmidt K., Kapitan M., Rudel E., Wessely P., Wöber-Bingöl Ç, the PAMINA Study Group. Prospective analysis of factors related to migraine attacks: the PAMINA study. Cephalalgia 27: 304-314 (2007)

19. Prince P.B., Rapoport A.M., Sheftell F.D., Tepper S.J., Bigal M.E.: The effect of weather on headache. Headache 44: 596-602 (2005)

20. MacGregor E.A., Hackshaw A.: Prevalence of migraine on each day of the natural menstrual cycle. Neurology 63: 351-353 (2004)

21. MacGregor E.A.: Oestrogen and attacks of migraine with and without aura. Lancet Neurol. 3: 354-361 (2004)

22. Holzhammer J., Wöber C.: Nichtalimentäre Triggerfaktoren bei Migräne und Kopfschmerz vom Spannungstyp. Schmerz 20: 226-237 (2006)

23. Rothner A.D.: Classification, pathogenesis, evaluation and management of headaches in children and adolescents. Curr. Opin. Pediatr. 4: 949-956 (1992)

24. Saper J.R.: Migraine II. Treatment. JAMA 239: 2480-2484 (1978)

25. Chabriat H., Danchot J., Michel P., Joire J.E., Henry P.: Precipitating factors of headache. A prospective study in a national control-matched survey in migraineurs and nonmigraineurs. Headache 39: 335-338 (1999)

26. Oleson J.: The international classification of headache disorders. Cephalalgia 24: 1-160 (2004)

27. Winner P., Wagrewski W., Gladstein J., Linder S.: Multicenter perspective evaluation of proposed pediatric migraine revisions to the HIS criteria. Headache 37: 545-548 (1997)

28. Winner P., Martinez W., Mate L., et al.: Classifications of pediatric migraine: proposed revisions to the HIS criteria. Headache 35: 407-410 (1995)

29. Rothner A.D.: Headaches in children: A review. Headache 19: 156-161 (1979)

30. Rothner A.D.: Classification, pathogenesis, evaluation and management of headaches in children and adolescents. Curr. Opin. Pediatr. 4: 949-956 (1992)

31. Elser J.M., Woody R.C.: Migraine in the infant and young child. Headache 30: 366-368 (1990)

32. Barlow C.F.: Migraine in the infant toddler. J. Child Neurol. 9: 92-94 (1994)

33. Davidoff R.A.: Clinical manifestations of migraine. In: (Davidoff R.A., ed) Migraine: Manifestations, Pathogenesis and Managament. Pp44-76, Davis, Philadellphia, PA, 1995

34. Millichap J.G.: Recurrent headaches in 100 children. Electroencephalic abnormalities and response to phenytoin. Childs Brain 4: 95-104 (1978)

35. Hachinski V.C, Porchawka J., Steele J.C.: Visual symptoms in the migraine syndrome. Neurology 23: 570-589 (1973)

36. Siow H.C, Welch K.M.A.: Basilar migraine. In: (Gilman S., ed.) MedLink Neurology. MedLink Corp., San Diego, 2004

37. Lapkin M.L., Golden G.S.: Basilar artery migraine, a review of 30 cases. Am. J. Dis. Child 132: 278-281 (1978)

38. Golden G.S., French J.H.: Basilar artery migraine in young children. Pediatrics 56: 722-726 (1975)

39. Congdom P.J, Forsythe W.I: Migraine in childhood: A study of 300 children. Dev. Med. Child Neurol. 21: 209-216 (1979)

40. Shinnar S.D., Souza B.: Migraine in children and adolescents. Pediatr. Rev. 3: 257-262 (1982)

41. Edmeads J.: Complicated migraine and headache in cerebrovascular disease. Neurol. Clin. North Am. 1: 385-397 (1983)

42. Glista G.G., Mellinger J.F., Rooke E.D.: Familial hemiplegic migraine. Mayo Clin. Proc. 50: 307-311 (1975)

43. Jensen S., Olivarius T., Kroft B., et al: Familial hemiplegic migraine-A reappraisal and long-term follow-up study. Cephalalgia 1: 33-39 (1981)

44. Joutel A., Bousser M.G., Biouse V., et al.: A gene for familial hemiplegic migraine maps to chromosome 19. Nat. Genet. 5: 40-45 (1993)

45. Yim G.K., Nordli D.R., Kandji A.G., et al,: Familial hemiplegic migraine: Autosomal-dominant condition linked to chromosome 19. Pediatr. Neurol. 11: 140 (1994)

46. Davidoff R.A.: Benign paroxysmal vertigo of childhood. In: (Gilman S, ed.) MedLink Neurology. MedlinkCorp., San Diego: Available at www.medlink.com, 2004

47. Lindskog U., Odkvist L., Noaksson L., et al.: Benign paroxysmal vertigo in childhood: a long-term follow-up. Headache 39: 33-37 (1999)

48. Fleischer D.R, Matar M.: The cyclic vomiting syndrome: A report of 71 cases and literature review. J. Pediatr. Gastroenterol. Nutr. 17: 361-369 (1993)

49. Symon D.N.: Is there a place for “abdominal migraine” as a separate entity in the I.H.S. classification? Yes! Cephalalgia 12: 345-346 (1992)

50. Lewis D.W.: Migraine and migraine variants in children and adolescents. Semin. Pediatr. Neyrol. 2: 127-143 (1995)

51. Singer H.S.: Migraine headaches in children. Pediatr. Rev. 15: 94-103 (1994)

52. Hamalainen M.C., Hoppo K., Valkeila E., et al.: Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo controlled crossover study. Neurology 48: 103-107 (1997)

53. Εθνικό Συνταγολόγιο: Εθνικός Οργανισμός Φαρμάκων. Pp. 240-243, Αθήνα, 2003

54. Εθνικό Συνταγολόγιο: Εθνικός Οργανισμός Φαρμάκων. Pp. 495-497, Αθήνα 2003

55. Εθνικό Συνταγολόγιο: Εθνικός Οργανισμός Φαρμάκων. Pp. 506-507, Αθήνα 2003

56. Εθνικό Συνταγολόγιο: Εθνικός Οργανισμός Φαρμάκων. Pp. 251, Αθήνα 2003

57. Εθνικό Συνταγολόγιο: Εθνικός Οργανισμός Φαρμάκων. Pp. 59-60, Αθήνα 2003

58. Εθνικό Συνταγολόγιο: Εθνικός Οργανισμός Φαρμάκων. Pp. 233-36, Αθήνα 2003

59. Hamalainen M.: Sumatriptan for migraine attacks in children: A randomized placebo-controlled study, Do children with migraine respond to oral sumatriptan differently that adults? Neurology 48: 1100-1103 (1997)

60. Winner P., Prensky A.,Linder S., et al.: Adolescent migraine efficacy and safety of sumatriptan tablets. J. Neurol. Sci. 150: S172 (1997)

61. Winner P., Rothner A.D., Saper J., Nett R., Asgharnejad M., Lavrenza A., et al.: A randomized, double-blind, plcebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 106: 989-997 (2000)

62. Winner P., Rothner A., Webster C., Ames M.: Overall efficacy of sumatriptan nasal spray in adolescent migraineurs pooled results from US Placebo-Controlled Trials. Headache 44: 465 (2004)

63. Linder S.L., Dowson A.J.: Zolmitriptan provides effective migraine relief in adolescents. Int. J. Clin. Prac. 54: 466-469 (2000)

64. Lewis D.W, Winner P.: The pharmacological treatment options for pediatric migraine: An evidence based appraisal. Neurol. Rx 3: 181-191 (2006)

65. Ramadan N., Metal.: Evidence-based guidelines for migraine headache in the primary case settings pharmacological management for preventional migraine. Neurol-ogy, 2000) [http://www.neurology.org]

66. Gray R.N. et al.: Drug treatments for the prevention of migraine headache. Prepared for the Agency for Health Care Policy and Research Contract 290-94-2025. National Technical Information Service Accession no 127953, 1999

67. Evans R.W, Mathew T.N.: Headaches during Childhood and Adolescence. Pp. 209-220, Lippincott Williams & Wilkins, 2005

68. Hershey A.D, Powers S.W, Vockell A.L, et al.: Effectiveness of topiramate in the prevention of childhood headaches. Headache 42: 810-818 (2002)

69. Younkin D.P.: Topiramate in the treatment of pediatric migraine. Headache 42: 456 (2002)

70. Ferreia, GarciaN., Pedreira L.: A case series of topiramate in pediatric and adolescent migraine prophylaxis. Headache 42: 453 (2002)

71. Serdaroglu G., Erhan E., Tekgul et al.: Sodium valproate prophylaxis in childhood migraine. Headache 42: 819-822 (2002)

72. Silberstein S.D.: Divalproex sodium in headache: literature review and clinical guidelines. Headache 36: 547-555 (1996)

73. Batistella P.A, Ruffill R., Moro R., et al.: A placebo-controlled crossover trial of nimodipine in pediatric migraine. Headache 30: 519-525 (1990)

74. Lewis D.W., Middlebrook M.T., Mehallick, et al.: Naproxen for migraine prophylaxis. Ann. Neurol. 36: 542-543 (1994)

75. Silberstein S.D., et al.: Botulinum toxin type A a migraine preventive treatment. For the BOTOX® Migraine Clinical Research Group. Headache 40: 445-450 (2000)

76. Hadjicosta C., Dokos Ch, Mironidou-Tzouveleki M.: Receptors in the pathophysiology of migraine: Facing a highly promising anti-migraine target. Aristotle University Med. J. 35: 7-13 (2008)